Advanced QC Solutions for Cell and Gene Therapy Manufacturing
Cell and gene therapies hold enormous potential for treating diseases like cancer and rare conditions. However, ensuring their safety and efficacy requires rigorous quality control throughout the manufacturing process.
bioMérieux's Comprehensive Portfolio
bioMérieux offers automated solutions to support the development and manufacturing process, ensuring quality, safety, and efficacy. The portfolio includes:
- 3P® ECOSYSTEM for Environmental Monitoring (EM): digitizes and automates EM, enhancing productivity and ensuring data integrity.
- BIOFIRE® for Mycoplasma Testing: provides fully-automated mycoplasma testing with results in under an hour, saving time and money.
- BACT/ALERT® for Sterility Testing: offers flexible contamination testing with dual temperature capabilities, ensuring optimized detection.
- Accellix for Cellular Viability, Phenotype, and Purity: provides comprehensive diagnostics for cellular quality attribute testing.
Streamlined QC testing specific to cell and gene therapies ensures safe, rapid, and efficient results. With bioMérieux’s automated solutions, you can bring safe and effective products to patients quickly.
Watch our detailed video to learn more about how bioMérieux solutions can support your cell and gene therapy development and manufacturing process: